Last quarter (Q3 2023), Rakovina Therapeutics Inc's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Rakovina Therapeutics Inc's net income was C$-646.97K. See Rakovina Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21
Total Revenue	-	-	-
Cost of Revenue	-	-	-
Gross Profit	-	-	-
Operating Expense	C$ 2.47M	C$ 2.82M	C$ 2.47M
Operating Income	C$ -2.47M	C$ -2.82M	C$ -2.47M
Net Non Operating Interest Income Expense	C$ -93.05K	C$ 28.27K	C$ -8.54K
Other Income Expense	-	-	C$ -3.06M
Pretax Income	C$ -2.54M	C$ -2.79M	C$ -5.52M
Tax Provision	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	C$ -2.54M	C$ -2.79M	C$ -5.52M
Basic EPS	C$ -0.04	C$ -0.04	C$ -0.10
Diluted EPS	C$ -0.04	C$ -0.04	C$ -0.10
Basic Average Shares	C$ 279.32M	C$ 69.83M	C$ 53.62M
Diluted Average Shares	C$ 279.32M	C$ 69.83M	C$ 53.62M
Dividend Per Share	-	-	-
Total Operating Income As Reported	-	-	-
Reported Normalized Basic E P S	-	-	-
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Total Expenses	C$ 2.47M	C$ 2.82M	C$ -2.47M
Net Income From Continuing And Discontinued Operation	C$ -2.54M	C$ -2.79M	C$ -5.52M
Normalized Income	C$ -1.86M	C$ -2.05M	C$ -5.52M
Interest Expense	-	-	-
EBIT	C$ -2.45M	C$ -2.79M	C$ -5.51M
EBITDA	C$ -1.91M	C$ -2.26M	-

Currency in CAD

Rakovina Therapeutics Inc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing